课题基金 / 基金详情

Lipid sensing through small G protein prenylation

Lipid sensing through small G protein prenylation
通过小 G 蛋白异戊二烯化进行脂质传感
批准号:
10439491
负责人:
Peter Mahan Douglas
金额:
$33.61万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-08-01 至 2022-07-31

项目摘要

项目成果

Peter Mahan Douglas的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要/摘要 脂质信号在调节机体生理和代谢支出方面起着至关重要的作用。 脂质平衡的失衡会有害地影响健康,机体内的细胞会受到严格的调节 脂肪的吸收、合成和代谢,以适应能量需求,确保能量储备 在以后的生活中。细胞通过SREBP调节在充足的代谢资源下储存能量储备 脂肪生成作用。然而,不太清楚的是,细胞如何在营养耗竭的条件下和在 特别是,细胞如何感知新陈代谢需求并通过增加营养吸收来做出反应。我们的考试 在线虫体内的几种脂质耗竭范例中,已经确定了一种高度响应的小G蛋白RAB-11.2, 该基因在类异戊二烯/甲氧戊酸合成途径缺陷时被转录激活。穿过 进一步的研究,我们发现了一种新的机制,将核质动力学联系在一起 核激素受体NHR-49与RAB-11.2的营养吸收有关。 通过建议的五年研究期,我们的目标是定义细胞感知的分子机制 并响应他们对从头合成脂肪的需求。我们的初步数据表明,细胞感觉到它们的 通过监测合成的特定戊烯醇脂的可用性来分解脂质的能力 类异戊二烯途径,香叶基香叶基焦磷酸。在高稳态血脂水平的情况下, RAB-11.1的香叶酰化使其能够结合和隔离NHR-49与胞浆运输囊泡。 转录不活跃状态。在饥饿或脂解缺陷/β引起的脂质限制条件下- 氧化,细胞缺乏通过类异戊二烯途径合成GGPP的资源,这阻止了RAB- 11.1结合小泡并扰乱营养吸收所需的内吞循环途径。由于 由于其RAB-11.1结合伙伴不能与囊泡结合,NHR-49从胞浆囊泡中释放出来,并 转位到细胞核,在那里它激活了几种代谢酶、营养转运蛋白的转录 和RAB-11.2来重建营养吸收。
英文摘要
Project Summary/Abstract Lipid signaling plays a critical role in the regulation of organismal physiology and metabolic expenditure. Imbalances in lipid homeostasis can deleteriously impact health and cells within the organism tightly regulate lipid absorption, synthesis and metabolism to accommodate energetic demands and ensure energetic reserves later in life. Cells stockpile energy reserves under ample metabolic resources through SREBP-regulated lipogenesis. Yet, less clear is how cells regulate lipid homeostasis under nutrient depleted conditions and in particular, how cells sense metabolic demand and respond by increasing nutrient absorption. Our examination of several lipid depletion paradigms in C. elegans has identified a highly responsive small G protein, RAB-11.2, which is transcriptionally activated upon defects in the isoprenoid/mevalonate synthesis pathway. Through further investigation, we have discovered a new mechanism linking the nucleocytoplasmic dynamics of the nuclear hormone receptor, NHR-49, with nutrient absorption through RAB-11.2. Through the proposed five-year research period, we aim to define the molecular mechanism by which cells sense and respond to their need for de novo lipid synthesis. Our preliminary data suggests that cells sense their capacity to breakdown lipids through monitoring the availability of a particular prenol lipid synthesized through the isoprenoid pathway, geranylgeranyl pyrophosphate. Under conditions of high homeostatic lipid levels, geranylgeranylation of RAB-11.1 enables it to bind and sequester NHR-49 to cytosolic transport vesicles in a transcriptionally inactive state. Under lipid limited conditions caused by starvation or defective lipolysis/β- oxidation, cells lack the resources to synthesize GGPP through the isoprenoid pathway, which prevents RAB- 11.1 from binding vesicles and disrupts endocytic recycling pathways required for nutrient absorption. Due to the inability of its RAB-11.1 binding partner to associate with vesicles, NHR-49 is release from cytosolic vesicles and translocates to the nucleus where it activates transcription of several metabolic enzymes, nutrient transporters and RAB-11.2 to re-establish nutrient absorption.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lipid sensing through G protein geranylgeranylation
  • 批准号:
    10417568
  • 项目类别:
  • 资助金额:
    $33.59万
  • 财政年份:
    2022
  • 负责人:
    Peter Mahan Douglas
  • 依托单位:
Lipid sensing through G protein geranylgeranylation
  • 批准号:
    10617820
  • 项目类别:
  • 资助金额:
    $34.26万
  • 财政年份:
    2022
  • 负责人:
    Peter Mahan Douglas
  • 依托单位:
Heat Shock Factor mediates actin phosphorylation in tissue integrity and age
  • 批准号:
    9902289
  • 项目类别:
  • 资助金额:
    $33.21万
  • 财政年份:
    2019
  • 负责人:
    Peter Mahan Douglas
  • 依托单位:
Heat Shock Factor mediates actin phosphorylation in tissue integrity and age
  • 批准号:
    10565858
  • 项目类别:
  • 资助金额:
    $33.21万
  • 财政年份:
    2019
  • 负责人:
    Peter Mahan Douglas
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
  • 批准号:
    82505677
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    吕雨霏
  • 依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
  • 批准号:
    82574874
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2025
  • 负责人:
    刘天华
  • 依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: